p14 ARF (ARF 4C6/4) Antibody sc-53392 from Santa Cruz Biotechnology, Inc.

Product Specs
Itemp14 ARF (ARF 4C6/4) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-53392
NCBI Gene AliasesARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16
Antibody TypePrimary Antibodies
Quantity200 µg/ml
CloneARF 4C6/4
ApplicationsWB, IP, IF, IHC(P)
Reactivityhuman
ClonalityMonoclonal
Hostmouse
Conjugate/TagUnconjugated
FormatPurified
NCBI Full Gene Namecyclin dependent kinase inhibitor 2A
Targetp14 ARF
IsotypeIgG2a

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Distinct nuclear and cytoplasmic assemblies and interactomes of the mammalian CTLH E3 ligase complexJournal of cell scienceJuly 15, 2022Onea G, Maitland MER, Wang X, Lajoie GA, Schild-Poulter C.

(2) P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune MicroenvironmentFrontiers in oncologyJanuary 1, 2021Pezzuto F, Lunardi F, Vedovelli L, Fortarezza F, Urso L, Grosso F, Ceresoli GL, Kern I, Vlacic G, Faccioli E, et al.

(3) Salidroside induces apoptosis in human ovarian cancer SKOV3 and A2780 cells through the p53 signaling pathwayOncology lettersMay 1, 2018Yu G, Li N, Zhao Y, Wang W, Feng XL.Cip1/Waf1 (cat. no. 610233; 1:500 dilution; BD Biosciences, Franklin Lakes, NJ, USA), p16 INK4a (cat. no. sc‑53392; Santa Cruz Biotechnology, Santa Cruz, CA, USA), Bcl‑2‑associated X protein (Bax) (cat. no. 5020; 1:1,000

(4) Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell modelsTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJanuary 1, 2016Gravina GL, Mancini A, Scarsella L, Colapietro A, Jitariuc A, Vitale F, Marampon F, Ricevuto E, Festuccia C.

(5) Cyclin-dependent kinase inhibitors, p16 and p27, demonstrate different expression patterns in thymoma and thymic carcinomaGeneral thoracic and cardiovascular surgeryNovember 1, 2014Omatsu M, Kunimura T, Mikogami T, Shiokawa A, Masunaga A, Nagai T, Kitami A, Suzuki T, Kadokura M.

(6) Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2Molecular cancer therapeuticsApril 1, 2013van Leeuwen IM, Higgins M, Campbell J, McCarthy AR, Sachweh MC, Navarro AM, Laín S.

(7) p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2Breast cancer research : BCRJanuary 1, 2004Vestey SB, Sen C, Calder CJ, Perks CM, Pignatelli M, Winters ZE.

p14 ARF (ARF 4C6/4) Antibody